R&D Document (SAP) Coordinator
embecta
R&D Document (SAP) Coordinator
embecta
Manufactures insulin delivery devices worldwide
embecta is a global medical device company with a 100-year legacy in insulin delivery and diabetes care. Driven by innovation, purpose, and a commitment to improving lives, we are expanding our portfolio of solutions to serve even more patients, healthcare providers, and communities around the world.
We are seeking a meticulous and detail-oriented R&D Document (SAP) Coordinator to join our team. As an R&D Document (SAP) Coordinator, your primary responsibility will be managing and maintaining accurate documentation within our documentation (SAP) system. You’ll play a critical role in ensuring compliance, version control, and efficient access to essential documents.
Responsibilities:
Document Control:
Documentation (SAP) System Management:
Collaboration and Communication:
Continuous Improvement:
Experience and Education
#LI-HYBRID
#LI-DF1
embecta is an Equal Opportunity/Affirmative Action Employer. We do not unlawfully discriminate on the basis of race, color, religion, age, sex, creed, national origin, ancestry, citizenship status, marital or domestic or civil union status, familial status, affectional or sexual orientation, gender identity or expression, genetics, disability, military eligibility or veteran status, or any other protected status.
Embecta designs, manufactures, and sells insulin delivery devices such as pen needles, insulin syringes, and safety injection devices for diabetes patients around the world. Its products are used to inject insulin and include disposable components like Nano and Ultra-Fine needles, with a tubeless insulin patch pump once pursued but later refocused on core injection devices. The company differentiates itself as a dedicated diabetes injection devices supplier with a global manufacturing footprint and an established distribution network, originating as a BD spin-off. Embecta aims to grow through strategic expansion, including an announced plan to acquire Owen Mumford to broaden into drug-delivery platforms beyond diabetes.
Explore more opportunities at embecta